immunai.comHealthcareFounded: 2018Funding to Date: $295.22MM
Immuani develops solutions for oncology treatments and auto-immune disorders by utilizing AI and ML technology to assist in mapping and to provide insights into the reprogramming of the immune system.
For more details on financing and valuation for Immunai, register or login.
View Enterprise Value for Immunai.
To read this article and more news on Immunai, register or login.